Guard Therapeutics International AB (FRA:5LH0) E10: €-3.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5LH0 Guard Therapeutics International AB FRA:5LH0
25 GF Score
Price €0.12
! 1 Warning Sign
View Full Analysis

What is Guard Therapeutics International AB E10?

Guard Therapeutics International AB FRA:5LH0 -3.41% 25 E10 is €-3.11 as of Mar. 2026. GuruFocus rates FRA:5LH0 with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Guard Therapeutics International AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.029. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-3.11 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Guard Therapeutics International AB was 16.60% per year. The lowest was 5.20% per year. And the median was 10.90% per year.

As of today (2026-07-22), Guard Therapeutics International AB's current stock price is €0.1248. Guard Therapeutics International AB's E10 for the quarter that ended in Mar. 2026 was €-3.11. Guard Therapeutics International AB's Shiller PE Ratio of today is .


Guard Therapeutics International AB  (FRA:5LH0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Guard Therapeutics International AB E10 Related Terms


Guard Therapeutics International AB E10 Historical Data

* Premium members only.

The historical data trend for Guard Therapeutics International AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB E10 Chart

Guard Therapeutics International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.93 -18.33 -20.10 -16.28 -2.58

Guard Therapeutics International AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.42 -13.72 -13.03 -2.58 -3.11

FRA:5LH0 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Guard Therapeutics International AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guard Therapeutics International AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guard Therapeutics International AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Guard Therapeutics International AB's Shiller PE Ratio falls into.


FRA:5LH0
25GF Score
Guard Therapeutics International AB FRA:5LH0
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guard Therapeutics International AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guard Therapeutics International AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.029/133.5600*133.5600
=-0.029

Current CPI (Mar. 2026) = 133.5600.

Guard Therapeutics International AB Quarterly Data

per share eps CPI Adj_EPS
201606 -10.470 101.019 -13.843
201609 -12.447 101.138 -16.437
201612 -19.616 102.022 -25.680
201703 -15.820 102.022 -20.711
201706 -6.215 102.752 -8.078
201709 -6.237 103.279 -8.066
201712 -4.130 103.793 -5.314
201803 -4.699 103.962 -6.037
201806 -1.811 104.875 -2.306
201809 -2.012 105.679 -2.543
201812 -6.817 105.912 -8.597
201903 -0.580 105.886 -0.732
201906 -0.397 106.742 -0.497
201909 -0.269 107.214 -0.335
201912 -1.416 107.766 -1.755
202003 -0.265 106.563 -0.332
202006 -0.241 107.498 -0.299
202009 -0.368 107.635 -0.457
202012 -0.202 108.296 -0.249
202103 -0.283 108.360 -0.349
202106 -0.237 108.928 -0.291
202109 -0.754 110.338 -0.913
202112 -0.420 112.486 -0.499
202203 -0.273 114.825 -0.318
202206 -0.271 118.384 -0.306
202209 -0.400 122.296 -0.437
202212 -0.481 126.365 -0.508
202303 -0.339 127.042 -0.356
202306 -0.270 129.407 -0.279
202309 -0.188 130.224 -0.193
202312 -0.146 131.912 -0.148
202403 -0.122 132.205 -0.123
202406 -0.206 132.716 -0.207
202409 -0.233 132.304 -0.235
202412 -0.184 132.987 -0.185
202503 -0.254 132.825 -0.255
202506 -0.151 133.699 -0.151
202509 -0.118 133.480 -0.118
202512 -0.074 133.390 -0.074
202603 -0.029 133.560 -0.029

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-3.11 mean?
Guard Therapeutics International AB (FRA:5LH0) has a E10 of €-3.11 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Guard Therapeutics International AB and its competitors.
Is Guard Therapeutics International AB's E10 too high?
Guard Therapeutics International AB's current E10 is €-3.11. Overall, Guard Therapeutics International AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Guard Therapeutics International AB's E10 compare to VRTX and REGN?
Guard Therapeutics International AB's E10 of €-3.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Guard Therapeutics International AB and its competitors. Guard Therapeutics International AB's current E10 is €-3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guard Therapeutics International AB stock overvalued right now?
Guard Therapeutics International AB (FRA:5LH0) has a current E10 of €-3.11. The current E10 is €-3.11. Guard Therapeutics International AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Guard Therapeutics International AB (FRA:5LH0), the current E10 is €-3.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guard Therapeutics International AB Business Description

Other Exchanges GUARD:Sweden
Address Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
25GF Score

Get the complete analysis for FRA:5LH0

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price